Why Wegovy 1.7 mg Pricing Should Never Surprise You
Wegovy 1.7 mg No Hidden Fees — Complete Price Transparency
The online pharmacy market is notorious for hidden charges that appear at checkout. Many competitors advertise Wegovy 1.7 mg at seemingly competitive rates, only to add consultation fees, prescription charges, and admin costs that can increase your total by £40 or more. At EverydayMeds, our Wegovy 1.7 mg price of £139.99 includes absolutely everything you need. Your clinical assessment, prescriber review, prescription issuance, medication supply, and next-day cold-chain delivery are all covered in this single transparent price.
This matters particularly for Wegovy 1.7 mg patients who are approaching maintenance therapy. You're planning long-term treatment costs, and surprise fees can derail your budgeting. Our GPhC-registered pharmacy (#9012878) believes in radical transparency because weight management is already challenging enough without financial uncertainty. What you see on our product page is exactly what appears on your card statement — no exceptions, no asterisks, no fine print revealing additional charges.
Wegovy 1.7 mg Pricing Structure and Bundle Options
Wegovy 1.7 mg represents weeks 13-16 of your dose escalation, priced at £139.99 as a single pen. For returning customers, code DOSE25 applies at checkout, while new patients use FIRST40 to access these final prices. The Consistency 1.7mg bundle provides two pens for £309.99, ideal if you need to stay at this dose longer than the standard four weeks. Our most popular option for 1.7mg patients is the Elevate Duo (1.7mg + 2.4mg) at £369.99, which seamlessly transitions you from your current dose to maintenance therapy.
Unlike other prescription-only medicine suppliers who calculate bundles inconsistently, our pricing structure rewards planning ahead with convenience rather than confusion. The Elevate Trio (1mg, 1.7mg, 2.4mg) costs £499.99 and covers your final dose escalation journey completely. These aren't just cost considerations — they're supply security for a medication that requires consistent weekly administration without gaps or delays in your treatment protocol.
Clinical Evidence for Wegovy 1.7 mg Effectiveness
In clinical trials, patients taking Wegovy alongside diet and exercise demonstrated their most significant weight loss momentum during the 1.7mg phase. The STEP 1 trial showed that patients achieved approximately 15% average weight loss at 68 weeks, with many reaching peak effectiveness during weeks 13-16 when receiving the 1.7mg dose. This phase represents the transition from dose-finding to therapeutic maintenance, where appetite suppression and satiety signals become most pronounced.
The SELECT cardiovascular outcomes trial, published by Wilding et al. in the New England Journal of Medicine (2021), demonstrated that semaglutide treatment resulted in a 20% reduction in major cardiovascular events. Patients at the 1.7mg dose level showed consistent GLP-1 receptor engagement, indicating that this penultimate dose delivers significant therapeutic benefit while preparing the body for the full 2.4mg maintenance dose that follows.
How Wegovy 1.7 mg Works as a GLP-1 Receptor Agonist
Wegovy 1.7 mg contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones responsible for glucose regulation and appetite control. At this dose level, semaglutide significantly reduces appetite by acting on the hypothalamic appetite centres in your brain, while simultaneously slowing gastric emptying to promote feelings of fullness after smaller meals. The 1.7mg concentration provides robust GLP-1 receptor activation without the initial gastrointestinal adjustment period experienced at lower doses. Your body has adapted to semaglutide's mechanism over the previous 12 weeks, allowing the 1.7mg dose to deliver maximum appetite suppression and metabolic benefits. This enhanced satiety signal helps maintain the reduced-calorie diet essential for optimal weight management outcomes during this crucial pre-maintenance phase.
Ordering Wegovy 1.7 mg Through EverydayMeds Process
Obtaining your Wegovy 1.7 mg prescription-only medicine begins with our comprehensive 3-minute online clinical assessment, designed specifically for patients progressing through dose escalation. Our questionnaire captures your current dose history, side effect profile, and weight management progress to ensure 1.7mg represents the appropriate next step in your treatment journey. Following submission, our prescriber team reviews your assessment within 3 working days (or 24 hours with express service), evaluating your suitability for this penultimate dose level. Once approved, your Wegovy 1.7 mg pen ships via next-day delivery using temperature-controlled logistics to maintain the 2-8°C storage requirements throughout transit. The entire process costs exactly £139.99 with no additional consultation fees, prescription charges, or delivery costs added at any stage.
Storage and Administration of Wegovy 1.7 mg FlexTouch Pen
Your Wegovy 1.7 mg arrives in Novo Nordisk's FlexTouch pre-filled pen, requiring refrigerated storage at 2-8°C until first use, after which it remains stable for up to 6 weeks at room temperature below 30°C. This extended room temperature stability makes Wegovy 1.7 mg more travel-friendly than many competing treatments, allowing greater flexibility in your weekly injection schedule. The FlexTouch pen delivers a precise 1.7mg dose with simple dial-and-inject operation, administered subcutaneously in your abdomen, thigh, or upper arm once weekly on the same day each week. After four weeks at this dose level, you'll progress to the final 2.4mg maintenance dose unless your prescriber determines you need additional time at 1.7mg for tolerance or effectiveness reasons. Always dispose of used pens in appropriate sharps containers and never share your FlexTouch pen with others, even if the needle is changed.
Why Wegovy 1.7 mg Transparency Matters for Long-Term Success
At the 1.7mg dose level, you're making critical decisions about long-term weight management commitment, and financial transparency directly impacts treatment adherence. Hidden fees create budgeting uncertainty that can lead to treatment interruptions, potentially compromising the momentum you've built over 12 weeks of dose escalation. EverydayMeds' transparent pricing for Wegovy 1.7 mg allows accurate cost planning as you transition to maintenance therapy. This predictability becomes essential when budgeting for ongoing 2.4mg maintenance treatment, where consistent monthly supply ensures uninterrupted GLP-1 receptor agonism.
Other online pharmacies may advertise competitive Wegovy 1.7 mg prices but reveal consultation fees ranging from £25-40 at checkout, prescription charges up to £15, or administrative fees that weren't disclosed upfront. These practices particularly impact patients at the 1.7mg stage who are evaluating long-term treatment costs and considering bundle options for supply security. Our commitment to complete price transparency means you can confidently plan your transition to maintenance therapy without financial surprises disrupting your weight management success.
Complete Your Wegovy 1.7 mg Order Today
Ready to continue your weight management journey with complete price transparency? Your Wegovy 1.7 mg prescription costs exactly £139.99 through our GPhC-registered pharmacy (#9012878), with returning customers applying code DOSE25 and new patients using FIRST40 at checkout to access these final prices. Consider the Elevate Duo bundle at £369.99 to secure both your current 1.7mg dose and the 2.4mg maintenance dose for seamless progression. Click through to https://everydaymeds.co.uk/products/wegovy-1-7mg to begin your clinical assessment and experience pharmaceutical retail without hidden fees or surprise charges. Your weight management success deserves financial clarity, and we're here to provide both the medication and the transparency you need for long-term success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
